Drugs like Ozempic, known collectively as GLP-1 receptor agonists, have become more widely used in recent years. Though they ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...

SINGAPORE-BASED global real estate logistics provider and investment manager, GLP, has found that modern technologies have improved its ability to better capture data and turn it into actionable ...

For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.

Discover how GLP-1 drugs like Ozempic and Mounjaro are transforming the fight against obesity. Learn the science, the risks, and the real-world results from experts on the front lines. Take control of ...

More and more people are considering using GLP-1 drugs for weight loss. But there are concerns about products being advertised as so-called "GLP-1 patches." Stream Connecticut News for free, 24/7, ...

A small new study suggests that people who’ve used GLP-1 drugs to reach a healthy weight can spread out their injections without regaining lost pounds.

While blockbuster drug innovations have changed health outcomes for decades, we’re now seeing signs that GLP-1 medications like Ozempic and Wegovy may be changing something broader: the consumer ...

Eli Lilly has a leading position in a hot new drug category, but there's one notable problem to consider.

The availability of compounded GLP-1 drugs shifted after the FDA changed their regulations in April 2025. Here’s what to know.